I agree that this site is using cookies. You can find further informations here.
X
López del Moral, Covadonga
54  results:
Search for persons X
?
1

#466 Comparison of CKDEPI vs EKFC equations in estimating g..:

Belotto, Miguel Martínez ; Ortega, María José ; Rodríguez, María...
Nephrology Dialysis Transplantation.  39 (2024)  Supplement_1 - p. , 2024
Link: https://doi.org/10.1093/..
 
?
2

Consequences of Nephrotic Proteinuria and Nephrotic Syndrom..:

Ortega, María José ; Martínez-Belotto, Miguel ; García-Majado, Cristina...
Biomedicines.  12 (2024)  4 - p. 767 , 2024
Link: https://doi.org/10.3390/..
 
?
3

#2120 Impact on CKD classification and comorbidities using ..:

Belotto, Miguel Martínez ; Ortega, María José ; Rodríguez, María...
Nephrology Dialysis Transplantation.  39 (2024)  Supplement_1 - p. , 2024
Link: https://doi.org/10.1093/..
 
?
4

The Clinical Utility of Post-Transplant Monitoring of Donor..:

van den Broek, Dennis A. J. ; Meziyerh, Soufian ; Budde, Klemens...
Transplant International.  36 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
5

Predictors of graft failure after first detection of de nov..:

López del Moral, Covadonga ; Wu, Kaiyin ; Naik, Marcel...
Nephrology Dialysis Transplantation.  39 (2023)  1 - p. 84-94 , 2023
Link: https://doi.org/10.1093/..
 
?
6

The natural history of de novo donor-specific HLA antibodie..:

López del Moral, Covadonga ; Wu, Kaiyin ; Naik, Marcel...
Frontiers in Medicine.  9 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
7

Poor Outcomes in Patients With Transplant Glomerulopathy In..:

Wu, Kaiyin ; Schmidt, Danilo ; López del Moral, Covadonga...
Frontiers in Medicine.  9 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
8

Temporary antimetabolite treatment hold boosts SARS-CoV-2 v..:

Schrezenmeier, Eva ; Rincon-Arevalo, Hector ; Jens, Annika...
JCI Insight.  7 (2022)  9 - p. , 2022
Link: https://doi.org/10.1172/..
 
?
9

Poor Long-Term Renal Allograft Survival in Patients with Ch..:

Wu, Kaiyin ; Schmidt, Danilo ; López del Moral, Covadonga...
Journal of Clinical Medicine.  11 (2021)  1 - p. 199 , 2021
Link: https://doi.org/10.3390/..
 
?
10

Low-risk delisting strategy in highly sensitized patients w..:

Comins-Boo, Alejandra ; Irure-Ventura, Juan ; Valentin, Maria O...
Human Immunology.  85 (2024)  3 - p. 110806 , 2024
Link: https://doi.org/10.1016/..
 
?
11

Should all patients with polycystic kidney disease be scree..:

López del Moral Cuesta, Covadonga ; Mazón Ruiz, Jaime ; Fernández Fresnedo, Gema
Nefrología (English Edition).  41 (2021)  6 - p. 702-703 , 2021
Link: https://doi.org/10.1016/..
 
?
12

¿Debería realizarse screening de aneurismas intracraneales ..:

López del Moral Cuesta, Covadonga ; Mazón Ruiz, Jaime ; Fernández Fresnedo, Gema
Nefrología.  41 (2021)  6 - p. 702-703 , 2021
Link: https://doi.org/10.1016/..
 
?
13

P1739IMMUNOSUPPRESSION WITH CALCINEURIN INHIBITOR AFTER REN..:

Ruiz San Millán, Juan Carlos ; López-Hoyos, Marcos ; San Segundo Arribas, David...
Nephrology Dialysis Transplantation.  35 (2020)  Supplement_3 - p. , 2020
Link: https://doi.org/10.1093/..
 
?
14

P1691URINARY CXCL10 AT SIX AND TWELVE MONTH PREDICTS SUBCLI..:

Rodrigo, Emilio ; Ruiz San Millán, Juan Carlos ; Valero San Cecilio, Rosalía...
Nephrology Dialysis Transplantation.  35 (2020)  Supplement_3 - p. , 2020
Link: https://doi.org/10.1093/..
 
?
15

Clinical experience with tolvaptan in patients with polycys..:

López del Moral Cuesta, Covadonga ; Fernández Fresnedo, Gema ; Martín Penagos, Luis
Medicina Clínica (English Edition).  155 (2020)  2 - p. 83-84 , 2020
Link: https://doi.org/10.1016/..
 
1-15